 Glaukos NYSE:GKOS shares are trading lower after Wells Fargo downgraded the stock from Equal-Weight to Underweight. Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company that focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. 